Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Minimally Invasive Neurosurgery Device Market by Device Type (Surgical Devices, Monitoring Visualization Devices, Endoscopy Devices) and by Surgery Type (Urological, Vascular, Cardiac, Gynecological, Gastrointestinal, Cosmetic, Bariatric, Thoracic, Breast, Orthopedic Surgeries): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03268

Pages: NA

Charts: NA

Tables: NA

Minimally invasive neurosurgery is carried out to treat disease occurring in various parts of brain, spinal cord, or skull base through a small opening. The minimally invasive procedures are gaining popularity over the conventional surgical procedures as these procedures cause low degree of trauma, require less recovery time, and a lesser duration of hospital stays.

Rise in the geriatric population and increase in incidence of target diseases such as cancer and neurological disorders are the major factors that drive the growth of minimally invasive neurosurgery device market. Furthermore, technological advancements in this field, increase in healthcare expenditure, and rise in demand for minimally invasive procedures boost the market growth. However, lack of skilled professionals and unstable reimbursement policies restrain the growth of market in developing countries. In addition, the lack of reimbursement and high costs of minimally invasive surgeries hinder the market growth.

The global minimally invasive neurosurgery device market is segmented based on device type, surgery type, and geography. Based on device type, the market is classified into surgical devices, monitoring and visualization devices, and endoscopy devices. Surgical device is further segmented into ablation devices, electrosurgical devices, and medical robotic systems. Ablation devices are further divided into radiofrequency ablation, microwave ablation, cryoablation, and others. Monitoring and visualization devices is further categorized into x-ray devices, computed tomography scanners, magnetic resonance imaging scanners, ultrasound equipment, and others. Based on surgery type, the market is categorized into urological, vascular, cardiac, gynecological, gastrointestinal, cosmetic, bariatric, thoracic, breast, and orthopedic surgeries. Orthopedic surgeries is further bifurcated into spinal surgery and joint replacement surgery. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Karl Storz GmbH & Co. KG, NICO Corp., Olympus Corporation, Medtronic, Conmed Corporation, Smith & Nephew Plc, Abbott Laboratories, Inc., GE Healthcare, NuVasive, Inc., and ArthroCare Corporation are also provided in this report.

Key Benefits

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global market.
  • This report entails the detailed quantitative analysis of the current market and estimations which assists to identify the prevailing market opportunities.
  • The projections in this report are made by analyzing the current trends and future market potential in terms of value.
  • Competitive intelligence (of leading manufacturers and distributors of disposable gloves) helps understand the competitive scenario across the geographies
  • An in-depth analysis of current research and clinical developments within market is provided with key market dynamic factors that helps understand the behavior of the market

 Key Market Segments

  • By Device Type
    • Surgical Devices
    • Monitoring & Visualization Devices
    • Endoscopy Devices
  • By Surgery Type
    • Urological
    • Vascular
    • Cardiac
    • Gynecological
    • Gastrointestinal
    • Cosmetic
    • Bariatric
    • Thoracic
    • Breast
    • Orthopedic Surgeries
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Medtronic
  • NuVasive, Inc.
  • Olympus Corporation
  • ArthroCare Corporation
  • NICO Corp.
  • Abbott Laboratories, Inc.
  • Smith & Nephew Plc
  • Karl Storz GmbH & Co. KG
  • GE Healthcare
  • Conmed Corporation

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET, BY DEVICE TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Device Type

    • 4.2. Surgical Devices

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Monitoring And Visualization Devices

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Endoscopy Devices

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET, BY SURGERY TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Surgery Type

    • 5.2. Urological

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Vascular

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cardiac

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Gynecological

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Gastrointestinal

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Cosmetic

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Bariatric

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

    • 5.9. Thoracic

      • 5.9.1. Key Market Trends, Growth Factors and Opportunities

      • 5.9.2. Market Size and Forecast, By Region

      • 5.9.3. Market Share Analysis, By Country

    • 5.10. Breast

      • 5.10.1. Key Market Trends, Growth Factors and Opportunities

      • 5.10.2. Market Size and Forecast, By Region

      • 5.10.3. Market Share Analysis, By Country

    • 5.11. Orthopedic Surgeries

      • 5.11.1. Key Market Trends, Growth Factors and Opportunities

      • 5.11.2. Market Size and Forecast, By Region

      • 5.11.3. Market Share Analysis, By Country

  • CHAPTER 6: MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Device Type

      • 6.2.3. Market Size and Forecast, By Surgery Type

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Minimally Invasive Neurosurgery Device Market

        • 6.2.5.1. Market Size and Forecast, By Device Type
        • 6.2.5.2. Market Size and Forecast, By Surgery Type

      • 6.2.6. Canada Minimally Invasive Neurosurgery Device Market

        • 6.2.6.1. Market Size and Forecast, By Device Type
        • 6.2.6.2. Market Size and Forecast, By Surgery Type

      • 6.2.7. Mexico Minimally Invasive Neurosurgery Device Market

        • 6.2.7.1. Market Size and Forecast, By Device Type
        • 6.2.7.2. Market Size and Forecast, By Surgery Type

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Device Type

      • 6.3.3. Market Size and Forecast, By Surgery Type

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Minimally Invasive Neurosurgery Device Market

        • 6.3.5.1. Market Size and Forecast, By Device Type
        • 6.3.5.2. Market Size and Forecast, By Surgery Type

      • 6.3.6. Germany Minimally Invasive Neurosurgery Device Market

        • 6.3.6.1. Market Size and Forecast, By Device Type
        • 6.3.6.2. Market Size and Forecast, By Surgery Type

      • 6.3.7. Italy Minimally Invasive Neurosurgery Device Market

        • 6.3.7.1. Market Size and Forecast, By Device Type
        • 6.3.7.2. Market Size and Forecast, By Surgery Type

      • 6.3.8. Spain Minimally Invasive Neurosurgery Device Market

        • 6.3.8.1. Market Size and Forecast, By Device Type
        • 6.3.8.2. Market Size and Forecast, By Surgery Type

      • 6.3.9. UK Minimally Invasive Neurosurgery Device Market

        • 6.3.9.1. Market Size and Forecast, By Device Type
        • 6.3.9.2. Market Size and Forecast, By Surgery Type

      • 6.3.10. Russia Minimally Invasive Neurosurgery Device Market

        • 6.3.10.1. Market Size and Forecast, By Device Type
        • 6.3.10.2. Market Size and Forecast, By Surgery Type

      • 6.3.11. Rest Of Europe Minimally Invasive Neurosurgery Device Market

        • 6.3.11.1. Market Size and Forecast, By Device Type
        • 6.3.11.2. Market Size and Forecast, By Surgery Type

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Device Type

      • 6.4.3. Market Size and Forecast, By Surgery Type

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Minimally Invasive Neurosurgery Device Market

        • 6.4.5.1. Market Size and Forecast, By Device Type
        • 6.4.5.2. Market Size and Forecast, By Surgery Type

      • 6.4.6. Japan Minimally Invasive Neurosurgery Device Market

        • 6.4.6.1. Market Size and Forecast, By Device Type
        • 6.4.6.2. Market Size and Forecast, By Surgery Type

      • 6.4.7. India Minimally Invasive Neurosurgery Device Market

        • 6.4.7.1. Market Size and Forecast, By Device Type
        • 6.4.7.2. Market Size and Forecast, By Surgery Type

      • 6.4.8. South Korea Minimally Invasive Neurosurgery Device Market

        • 6.4.8.1. Market Size and Forecast, By Device Type
        • 6.4.8.2. Market Size and Forecast, By Surgery Type

      • 6.4.9. Australia Minimally Invasive Neurosurgery Device Market

        • 6.4.9.1. Market Size and Forecast, By Device Type
        • 6.4.9.2. Market Size and Forecast, By Surgery Type

      • 6.4.10. Thailand Minimally Invasive Neurosurgery Device Market

        • 6.4.10.1. Market Size and Forecast, By Device Type
        • 6.4.10.2. Market Size and Forecast, By Surgery Type

      • 6.4.11. Malaysia Minimally Invasive Neurosurgery Device Market

        • 6.4.11.1. Market Size and Forecast, By Device Type
        • 6.4.11.2. Market Size and Forecast, By Surgery Type

      • 6.4.12. Indonesia Minimally Invasive Neurosurgery Device Market

        • 6.4.12.1. Market Size and Forecast, By Device Type
        • 6.4.12.2. Market Size and Forecast, By Surgery Type

      • 6.4.13. Rest of Asia Pacific Minimally Invasive Neurosurgery Device Market

        • 6.4.13.1. Market Size and Forecast, By Device Type
        • 6.4.13.2. Market Size and Forecast, By Surgery Type

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Device Type

      • 6.5.3. Market Size and Forecast, By Surgery Type

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Minimally Invasive Neurosurgery Device Market

        • 6.5.5.1. Market Size and Forecast, By Device Type
        • 6.5.5.2. Market Size and Forecast, By Surgery Type

      • 6.5.6. South Africa Minimally Invasive Neurosurgery Device Market

        • 6.5.6.1. Market Size and Forecast, By Device Type
        • 6.5.6.2. Market Size and Forecast, By Surgery Type

      • 6.5.7. Saudi Arabia Minimally Invasive Neurosurgery Device Market

        • 6.5.7.1. Market Size and Forecast, By Device Type
        • 6.5.7.2. Market Size and Forecast, By Surgery Type

      • 6.5.8. UAE Minimally Invasive Neurosurgery Device Market

        • 6.5.8.1. Market Size and Forecast, By Device Type
        • 6.5.8.2. Market Size and Forecast, By Surgery Type

      • 6.5.9. Argentina Minimally Invasive Neurosurgery Device Market

        • 6.5.9.1. Market Size and Forecast, By Device Type
        • 6.5.9.2. Market Size and Forecast, By Surgery Type

      • 6.5.10. Rest of LAMEA Minimally Invasive Neurosurgery Device Market

        • 6.5.10.1. Market Size and Forecast, By Device Type
        • 6.5.10.2. Market Size and Forecast, By Surgery Type

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Karl Storz GmbH And Co. KG

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. NICO Corp.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Olympus Corporation

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Medtronic

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Conmed Corporation

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Smith And Nephew Plc

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Abbott Laboratories, Inc.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. GE Healthcare

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. NuVasive, Inc.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. ArthroCare Corporation

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR SURGICAL DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR MONITORING AND VISUALIZATION DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR ENDOSCOPY DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR UROLOGICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR VASCULAR, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR CARDIAC, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR GYNECOLOGICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR GASTROINTESTINAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR COSMETIC, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR BARIATRIC, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR THORACIC, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR BREAST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR ORTHOPEDIC SURGERIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 20. U.S. MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 21. U.S. MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 22. CANADA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 23. CANADA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 29. FRANCE MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. GERMANY MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 32. GERMANY MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 33. ITALY MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 34. ITALY MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. SPAIN MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 36. SPAIN MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. UK MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 38. UK MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 39. RUSSIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 40. RUSSIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 41. REST OF EUROPE MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 42. REST OF EUROPE MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. ASIA-PACIFIC MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 44. ASIA-PACIFIC MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 45. ASIA-PACIFIC MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. CHINA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 47. CHINA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 48. JAPAN MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 49. JAPAN MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. INDIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 51. INDIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. SOUTH KOREA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 53. SOUTH KOREA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 54. AUSTRALIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 55. AUSTRALIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 56. THAILAND MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 57. THAILAND MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 58. MALAYSIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 59. MALAYSIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 60. INDONESIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 61. INDONESIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 62. REST OF ASIA PACIFIC MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 63. REST OF ASIA PACIFIC MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 64. LAMEA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 65. LAMEA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 66. LAMEA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 67. BRAZIL MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 68. BRAZIL MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH AFRICA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH AFRICA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. SAUDI ARABIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 72. SAUDI ARABIA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 73. UAE MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 74. UAE MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 75. ARGENTINA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 76. ARGENTINA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 77. REST OF LAMEA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY DEVICE TYPE, 2025-2033 ($MILLION)
  • TABLE 78. REST OF LAMEA MINIMALLY INVASIVE NEUROSURGERY DEVICE, BY SURGERY TYPE, 2025-2033 ($MILLION)
  • TABLE 79. KARL STORZ GMBH AND CO. KG: KEY EXECUTIVES
  • TABLE 80. KARL STORZ GMBH AND CO. KG: COMPANY SNAPSHOT
  • TABLE 81. KARL STORZ GMBH AND CO. KG: OPERATING SEGMENTS
  • TABLE 82. KARL STORZ GMBH AND CO. KG: PRODUCT PORTFOLIO
  • TABLE 83. KARL STORZ GMBH AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84. NICO CORP.: KEY EXECUTIVES
  • TABLE 85. NICO CORP.: COMPANY SNAPSHOT
  • TABLE 86. NICO CORP.: OPERATING SEGMENTS
  • TABLE 87. NICO CORP.: PRODUCT PORTFOLIO
  • TABLE 88. NICO CORP.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89. OLYMPUS CORPORATION: KEY EXECUTIVES
  • TABLE 90. OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • TABLE 91. OLYMPUS CORPORATION: OPERATING SEGMENTS
  • TABLE 92. OLYMPUS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 93. OLYMPUS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 94. MEDTRONIC: KEY EXECUTIVES
  • TABLE 95. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 96. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 97. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 98. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 99. CONMED CORPORATION: KEY EXECUTIVES
  • TABLE 100. CONMED CORPORATION: COMPANY SNAPSHOT
  • TABLE 101. CONMED CORPORATION: OPERATING SEGMENTS
  • TABLE 102. CONMED CORPORATION: PRODUCT PORTFOLIO
  • TABLE 103. CONMED CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 104. SMITH AND NEPHEW PLC: KEY EXECUTIVES
  • TABLE 105. SMITH AND NEPHEW PLC: COMPANY SNAPSHOT
  • TABLE 106. SMITH AND NEPHEW PLC: OPERATING SEGMENTS
  • TABLE 107. SMITH AND NEPHEW PLC: PRODUCT PORTFOLIO
  • TABLE 108. SMITH AND NEPHEW PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. ABBOTT LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 110. ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 111. ABBOTT LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 112. ABBOTT LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 113. ABBOTT LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 115. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 116. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 117. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 118. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. NUVASIVE, INC.: KEY EXECUTIVES
  • TABLE 120. NUVASIVE, INC.: COMPANY SNAPSHOT
  • TABLE 121. NUVASIVE, INC.: OPERATING SEGMENTS
  • TABLE 122. NUVASIVE, INC.: PRODUCT PORTFOLIO
  • TABLE 123. NUVASIVE, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. ARTHROCARE CORPORATION: KEY EXECUTIVES
  • TABLE 125. ARTHROCARE CORPORATION: COMPANY SNAPSHOT
  • TABLE 126. ARTHROCARE CORPORATION: OPERATING SEGMENTS
  • TABLE 127. ARTHROCARE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 128. ARTHROCARE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET
  • FIGURE 3. SEGMENTATION MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET
  • FIGURE 11. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET SEGMENTATION, BY BY DEVICE TYPE
  • FIGURE 12. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR MONITORING AND VISUALIZATION DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR ENDOSCOPY DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET SEGMENTATION, BY BY SURGERY TYPE
  • FIGURE 16. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR UROLOGICAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR VASCULAR, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR CARDIAC, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR GYNECOLOGICAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR GASTROINTESTINAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR COSMETIC, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR BARIATRIC, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR THORACIC, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR BREAST, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: MINIMALLY INVASIVE NEUROSURGERY DEVICE MARKET
  • FIGURE 32. TOP PLAYER POSITIONING, 2024
  • FIGURE 33. KARL STORZ GMBH AND CO. KG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. KARL STORZ GMBH AND CO. KG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. KARL STORZ GMBH AND CO. KG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. NICO CORP.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. NICO CORP.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. NICO CORP.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. OLYMPUS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. OLYMPUS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. OLYMPUS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. MEDTRONIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. MEDTRONIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. CONMED CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. CONMED CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. CONMED CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. SMITH AND NEPHEW PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. SMITH AND NEPHEW PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. SMITH AND NEPHEW PLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. ABBOTT LABORATORIES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. ABBOTT LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. ABBOTT LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. GE HEALTHCARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. NUVASIVE, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. NUVASIVE, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. NUVASIVE, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 60. ARTHROCARE CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 61. ARTHROCARE CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 62. ARTHROCARE CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Minimally Invasive Neurosurgery Device Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved